United States · Research startup

Fountain Therapeutics

Fountain Therapeutics is building a pipeline of therapeutics to treat age-related diseases by reversing cellular age.

Funding reportedLast round: Series A

ResearchSouth San Francisco, United States

About Fountain Therapeutics

Fountain Therapeutics is building a pipeline of therapeutics to treat age-related diseases by reversing cellular age.

The company has combined the expertise of leaders in aging research and computation to build an AI-driven platform that extracts previously hidden cellular features to measure aging with remarkable precision. Fountain is currently screening a large diversity of drug compounds, including small molecules and biologics, to identify novel drugs that specifically reverse the age of cells for the development of therapeutics to treat age-related diseases. Fountain is comprised of an exceptional growing team of scientists, engineers, physicians, drug hunters and developers, and entrepreneurs originating from top academic institutions, research laboratories and biotech companies in the world. The team is united by the common goal of building a new way forward to decouple aging from disease and improve the quality of life for our aging population. Fountain is based in South San Francisco, California. For more information on Fountain, please visit www.fountaintx.com.

What company datasets say Fountain Therapeutics raised

Funding, as reported

Reported in all$26Min dollars
Rounds3
Last roundSeries A
Last round size$15M
Last round dateNov 2021
Investors listed5
SEC Form D$32M sold, 4 filings, last Dec 2021

Founders and team

From the SEC filings it signed: 2 on the team.

  • Thomas RandoExecutive Officer, Directori
  • William GreeneExecutive Officer, Directori

On the board, as filediAlex MorganAshish Khanna

The company, in detail

What they build

Known for

health carehigh-content screeningin vitro screeningdisease pathwaysin vivo screeningphenotypic scoringbiotechnology researchmetabolic diseasescellular agingmedical researchdisease targetscirculating factorsmuscle atrophyphenotypic modelsmetabolic healthhigh-content analysis

Built with from their website

parallax.jsSquarespace ECommerceGoogle CloudGoogle WorkspaceViewport MetaGoogle Cloud HostingGoogle MeetPriority HintsMagento 2Mobile Friendly

+8 more

Magento Open SourceOpen GraphSquarespaceHSTSGoogle Cloud DNSSquarespace CommerceCart FunctionalityAdobe Fonts

Sector
Research
Industry code
NAICS 54171, SIC 2834
Region
California
Revenue
$1.7M a year, as listed
Full record
Every detail in the company directory

Research in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Fountain Therapeutics in front of investors. Or tell us what we have wrong.